{"id":17421,"date":"2017-07-01T05:00:44","date_gmt":"2017-07-01T13:00:44","guid":{"rendered":"http:\/\/cannabiscultivatornews.com\/home\/index.php\/2017\/07\/01\/5-misconceptions-about-cbd\/"},"modified":"2017-07-02T00:43:06","modified_gmt":"2017-07-02T08:43:06","slug":"5-misconceptions-about-cbd","status":"publish","type":"post","link":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2017\/07\/01\/5-misconceptions-about-cbd\/","title":{"rendered":"5 Misconceptions About CBD"},"content":{"rendered":"<\/p>\n<h4>Prominent researcher debunks some of the myths surrounding CBD.<\/h4>\n<hr \/>\n<p><span class=\"wpsdcp-drop-cap-default\">W<\/span>hile once ignored and widely unknown, cannabidiol or CBD continues to gain traction for its wide range of therapeutic applications. However, as its significance continues to grow, so do the misconceptions around the potential effects and uses of the cannabinoid. Within a <a href=\"http:\/\/www.cell.com\/trends\/pharmacological-sciences\/comments\/S0165-6147(16)30186-9\" target=\"_blank\" rel=\"noopener noreferrer\">report<\/a> published earlier this year in the scientific journal Cell Press, <a href=\"http:\/\/www.phytecs.com\/about-us\/team\/ethan-russo\/\" target=\"_blank\" rel=\"noopener noreferrer\">Dr. Ethan Russo<\/a> \u2014 a board-certified neurologist, psychopharmacology researcher and former senior Medical Advisor to <a href=\"https:\/\/cannabisnow.com\/?s=GW+Pharmaceuticals\">GW Pharmaceuticals<\/a> \u2014 seeks to dispel various misunderstandings that have arisen around the <a href=\"https:\/\/cannabisnow.com\/?s=CBD\">CBD<\/a> trend. In the report Russo highlights five misconceptions about CBD which are outlined below.<\/p>\n<p><strong>Misconception: CBD is Non-Psychoactive<\/strong><\/p>\n<p>While many articles and websites will point to CBD as \u201cnon-psychoactive\u201d in comparison to <a href=\"https:\/\/cannabisnow.com\/?s=THC\">THC<\/a> (the primary psychoactive cannabinoid present in cannabis), Russo points out that this is not an accurate representation.<\/p>\n<p>\u201cCBD is frequently mischaracterized as \u2018non-psychoactive\u2019 or \u2018non-pychotropic\u2019 in comparison to tetrahydrocannabinol (THC), but these terms are inaccurate, given its prominent pharmacological benefits on anxiety, schizophrenia, addiction, and possibly even depression,\u201d Russo writes. \u201cMore accurately, CBD should be preferably labeled as \u2018non-intoxicating,\u2019 and lacking associated reinforcement, craving, compulsive use, ect. that would indicate a significant drug abuse liability.\u201d<\/p>\n<p><strong>Misconception: CBD is Sedating<\/strong><\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15118485\" target=\"_blank\" rel=\"noopener noreferrer\">Early scientific reports<\/a> about CBD indicated that the cannabinoid might be an effective treatment for <a href=\"https:\/\/cannabisnow.com\/?s=insomnia\">insomnia,<\/a> however Russo notes that, in small doses, the exact opposite might actually be true.<\/p>\n<p>\u201cLow to moderate doses are distinctly alerting, as proven in [CBD\u2019s] ability to counteract sedative effects of THC, delay sleep time as documented via electroencephalography and reduce THC-associated \u2018hangover,\u2019\u201d Russo writes.<\/p>\n<p>The researcher points to <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18589404\" target=\"_blank\" rel=\"noopener noreferrer\">several studies<\/a>, in which patients using CBD, even those who were given up to 600 mg of CBD orally, did not experience sedative effects. In contrast, <a href=\"https:\/\/cannabisnow.com\/?s=Epidiolex\">Epidiolex<\/a> (a cannabis extract that contains THC and CBD which is expected to be eminently approved for pharmaceutical use in the U.S.) that was employed to treat epilepsy in very high doses of 25 mg or more a day, has produced sedative effects. Russo notes that this is especially true when Epidiolex is co-administered with the drug clobazam.<\/p>\n<p>Interestingly, Russo points out that the misconception that CBD is sedative is because many products containing the cannabinoid<em> actually<\/em> have high concentrations of the <a href=\"https:\/\/cannabisnow.com\/?s=terpene\">terpene<\/a> <a href=\"http:\/\/reset.me\/story\/myrcene-theres-more-to-marijuana-than-cannabinoids\/\" target=\"_blank\" rel=\"noopener noreferrer\">myrcene<\/a>. This terpene, which is also found in things like mangos, lemongrass and hops, is known for causing the \u2018couch-lock\u2019 effects in cannabis.<\/p>\n<p><strong>Misconception: CBD Works By Blocking Receptors<\/strong><\/p>\n<p>Even though some researchers have thought that CBD might be a CB1 Antagonist (which means it binds to cannabinoid receptors and prevents their activation) Russo points out that this is not the case. One known CB1 agonist, rimonabant was removed from the Eurpean market due to \u201cnumerous serious associated adverse events\u201d that included anxiety, suicidal ideation and nausea. Unlike this drug, Russo writes that CBD, particularly in the presence of THC, \u201cproduces none of the rimonabant-type adverse effects.\u201d<\/p>\n<p><strong>Misconception: CBD is Legal in All 50 States <\/strong><\/p>\n<p>This is a big one, because the first thing many hemp-based CBD companies tell consumers is that their product is legal in all the states in the U.S. Russo notes that while CBD is an unscheduled drug in most nations, \u201cthis is not the case in the USA, where, pharmacology notwithstanding, CBD has been a forbidden Schedule I agent with its own Drug Enforcement Administration (DEA) number and designation as a THC analog.\u201d<\/p>\n<p>Russo goes on to note that although the possession of hemp stalks and other certain plant parts \u201care not expressly forbidden\u201d by the Controlled Substances Act of 1970, \u201cchemical extraction of those parts clearly is.\u201d In addition, Russo points out that when Epidiolex becomes an approved drug in the U.S. as expected, its status \u201cwill not extend to CBD from other sources, which must remain in Schedule I until meeting similar standards of efficacy, safety, and consistency.\u201d<\/p>\n<p>\u201cOnly reclassification of CBD by the Food and Drug Administration and DEA, or an act of Congress, would alter this scheduling discrepancy and continuing anomaly,\u201d Russo writes.<\/p>\n<p><strong>Misconception: CBD Turns Into THC in the Body<\/strong><\/p>\n<p>Russo notes that the misconception that CBD turns to CBD within the body is one that has gained traction in online forums and even found credibility via <a href=\"http:\/\/online.liebertpub.com\/doi\/full\/10.1089\/can.2015.0004\" target=\"_blank\" rel=\"noopener noreferrer\">a scientific report<\/a> which points out the conversion may occur \u201cafter prolonged exposure to \u2018simulated\u2019 gastric acid.\u201d Despite this, Russo states that there is no evidence CBD converts to THC within the body.\u201d<\/p>\n<p><strong>TELL US,<\/strong> do you use CBD?<\/p>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/cannabisnow.com\/5-misconceptions-cbd\/\">5 Misconceptions About CBD<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/cannabisnow.com\">Cannabis Now<\/a>.<\/p>\n<p>&#013;<br \/>\n&#013;<br \/>\nRead More: <a href=\"https:\/\/cannabisnow.com\/5-misconceptions-cbd\/\" target=\"_blank\">5 Misconceptions About CBD<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Prominent researcher debunks some of the myths surrounding CBD. While once ignored and widely unknown, cannabidiol or CBD continues to gain traction for its wide range of therapeutic applications. However, as its significance continues to grow, so do the misconceptions around the potential effects and uses of the cannabinoid. Within<span class=\"more-link\"><a href=\"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2017\/07\/01\/5-misconceptions-about-cbd\/\">Continue Reading<\/a><\/span><\/p>\n","protected":false},"author":46,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[50,136,476,53],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/17421"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/46"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=17421"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/17421\/revisions"}],"predecessor-version":[{"id":17422,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/17421\/revisions\/17422"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=17421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=17421"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=17421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}